(TheRedWire.com) – A federal judge in Texas in an unprecedented decision decided to block access to one of the two abortion drugs, mifepristone in seven days. According to the ruling, the drug would not be able to be prescribed and distributed that has been on the market for over two decades.
District Court Judge Matthew Kacsmaryk, an appointee of former President Trump, allowed the government a window of one week in which they could appeal his decision and also seek an emergency relief ruling. On Friday, the FDA filed an appeal to the conservative 5th Circuit Court of Appeals.
In a separate case on Friday, U.S. District Judge Thomas Rice, an Obama appointee who sits in the Eastern District of Washington, blocked the FDA from “altering the status quo and rights as it relates to the availability of Mifepristone” in 17 states and Washington, D.C. in a lawsuit that argued that the drug was too heavily regulated.
The two rulings could have important effects on abortion access across the nation, while also potentially altering the authority that the Food and Drug Administration has. The dispute could potentially lead to the Supreme Court.
Kacsmaryk in his ruling sided with the anti-abortion group who in their lawsuit argued that the drug had been approved too fast, meaning that it was not a safe drug to be released in the market. Kacsmaryk agreed with this point and claimed that the FDA violated federal standards following its initial approval of mifepristone 23 years ago.
Copyright 2023, TheRedWire.com